Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molybdenum cofactor deficiency

G L Arnold1, C L Greene, J P Stout

  • 1Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock 72205.

The Journal of Pediatrics
|October 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hiccups and gastroesophageal reflux disease as seen on high resolution esophageal manometry.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2014
Same author

The well-read psychiatrist.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2014
Same author

Certain Fundamental Errors in the Diagnosis and Treatment of Myocardial Insufficiency.

Canadian Medical Association journal·2010
Same author

Guideline for the diagnosis and management of glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type I).

Journal of inherited metabolic disease·2007
Same author

Infant mice with glutaric acidaemia type I have increased vulnerability to 3-nitropropionic acid toxicity.

Journal of inherited metabolic disease·2006
Same author

Development of pathogenic concepts in glutaryl-CoA dehydrogenase deficiency: the challenge.

Journal of inherited metabolic disease·2004
Same journal

Standardized Mean Differences Reveal Substantial Selection Bias in Post-Reduction Management of Intussusception.

The Journal of pediatrics·2026
Same journal

Parenteral Lipid Dose and Bilirubin Neurotoxicity in Extremely Preterm Infants: A Factorial Randomized Trial.

The Journal of pediatrics·2026
Same journal

Refining Oxygen-Carrying Capacity Metrics in Assessing Mortality Risk from Pneumonia in Children.

The Journal of pediatrics·2026
Same journal

Time-to-Transfer and Hospitalization Duration for Severe Congenital Heart Defects: Implications for Perinatal Regionalization.

The Journal of pediatrics·2026
Same journal

Multimodal neuromonitoring in neonatal hypoxic-ischemic encephalopathy and the association with neurodevelopmental outcomes: A Multicenter Study.

The Journal of pediatrics·2026
Same journal

KP.2-Adapted BNT162b2 COVID-19 Vaccine Uptake and Effectiveness in Children.

The Journal of pediatrics·2026
See all related articles

Molybdenum cofactor deficiency is an underrecognized metabolic disorder causing neonatal seizures and neurological issues. Early diagnosis is key, aided by specific biochemical markers like hypouricemia and elevated urine sulfate.

Area of Science:

  • Biochemistry
  • Metabolic Disorders
  • Genetics

Background:

  • Molybdenum cofactor deficiency (MCD) is a rare, inherited metabolic disorder.
  • It is an underrecognized cause of severe neonatal neurological complications.

Observation:

  • This report details a new case of molybdenum cofactor deficiency.
  • The patient presented with neonatal seizures and significant neurologic abnormalities.

Findings:

  • Characteristic biochemical findings include hypouricemia (low uric acid levels).
  • Elevated urinary sulfate, detectable by simple dipstick testing, is another key indicator.
  • Elevated S-sulfocysteine, identified through anion exchange chromatography, further supports the diagnosis.

Implications:

Related Experiment Videos

  • Molybdenum cofactor deficiency should be strongly considered in the differential diagnosis of neonatal seizures.
  • Prompt identification of biochemical defects can facilitate timely intervention.
  • Increased awareness may improve outcomes for affected infants.